The pharmacist's role in thrombolytic therapy

Area of Science:

• Pharmacology
• Cardiology
• Clinical Pharmacy

Background:

• Thrombolytic agents are effective when administered early in acute myocardial infarction (AMI).
• The pharmacist's expertise is vital for the safe and effective use of these critical medications.

Purpose of the Study:

• To discuss the essential role of pharmacists in managing thrombolytic therapy for AMI.
• To outline pharmacist responsibilities in drug administration, selection, dosing, and evaluation.

Main Methods:

• Review of current thrombolytic agents (streptokinase, alteplase, anistreplase) for AMI.
• Summary of dosing, reconstitution guidelines, and ongoing research for optimal regimens.
• Examination of patient selection criteria and contraindications for thrombolytic therapy.

Main Results:

• Pharmacists are integral to establishing guidelines for patient selection, reconstitution, dosing, and concomitant therapies.
• Drug-use evaluation by pharmacists is essential for monitoring thrombolytic agent efficacy and safety.
• Current contraindications for thrombolytic therapy may warrant re-evaluation for specific patient subgroups.

Conclusions:

• Pharmacists can significantly expand their role in the drug-use process through thrombolytic therapy management.
• Ensuring appropriate use of thrombolytic agents enhances patient care and outcomes in AMI.
• Future research will guide the use of thrombolytic agents in previously excluded patient populations.